New, first-of-their-kind guidelines are advising pregnant women and new moms about how to safely use GLP-1 weight loss and diabetes drugs.
The guidelines aim to help OB-GYNs, who have seen GLP-1-use surge in the U.S. in recent years but lacked comprehensive instruction on whether or not to recommend the drugs.